Compare ADAG & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADAG | ACU |
|---|---|---|
| Founded | 2011 | 1867 |
| Country | China | United States |
| Employees | 138 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.3M | 154.0M |
| IPO Year | 2020 | 1994 |
| Metric | ADAG | ACU |
|---|---|---|
| Price | $2.96 | $46.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 108.8K | 7.4K |
| Earning Date | 01-01-0001 | 06-11-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | N/A | ★ $194,489,991.00 |
| Revenue This Year | $3,688.61 | $5.72 |
| Revenue Next Year | $17.39 | $5.19 |
| P/E Ratio | ★ N/A | $22.89 |
| Revenue Growth | N/A | ★ 1.56 |
| 52 Week Low | $1.33 | $35.31 |
| 52 Week High | $3.53 | $46.46 |
| Indicator | ADAG | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 60.12 |
| Support Level | $1.64 | $39.83 |
| Resistance Level | $3.19 | N/A |
| Average True Range (ATR) | 0.30 | 1.30 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 48.01 | 66.09 |
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.